title: Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection.
abstract: The regulation of proviral latency is a central problem in retrovirology. We postulate that the genomic integration site of human T lymphotropic virus type 1 (HTLV-1) determines the pattern of expression of the provirus, which in turn determines the abundance and pathogenic potential of infected T cell clones in vivo. We recently developed a high-throughput method for the genome-wide amplification, identification and quantification of proviral integration sites. Here, we used this protocol to test two hypotheses. First, that binding sites for transcription factors and chromatin remodelling factors in the genome flanking the proviral integration site of HTLV-1 are associated with integration targeting, spontaneous proviral expression, and in vivo clonal abundance. Second, that the transcriptional orientation of the HTLV-1 provirus relative to that of the nearest host gene determines spontaneous proviral expression and in vivo clonal abundance. Integration targeting was strongly associated with the presence of a binding site for specific host transcription factors, especially STAT1 and p53. The presence of the chromatin remodelling factors BRG1 and INI1 and certain host transcription factors either upstream or downstream of the provirus was associated respectively with silencing or spontaneous expression of the provirus. Cells expressing HTLV-1 Tax protein were significantly more frequent in clones of low abundance in vivo. We conclude that transcriptional interference and chromatin remodelling are critical determinants of proviral latency in natural HTLV-1 infection.
authors.affiliation: Department of Immunology, Wright-Fleming Institute, Imperial College London, London, United Kingdom.
authors.forename: Anat
authors.initials: A
authors.lastname: Melamed
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Laydon
authors.forename: Nicolas A
authors.initials: NA
authors.lastname: Gillet
authors.forename: Yuetsu
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Graham P
authors.initials: GP
authors.lastname: Taylor
authors.forename: Charles R M
authors.initials: CR
authors.lastname: Bangham
mesh_terms: D004279:DNA, Viral; D015967:Gene Expression Regulation, Viral; D016356:Gene Products, tax / Q000235:genetics / Q000378:metabolism; D018390:Gene Targeting; D055106:Genome-Wide Association Study; D015490:HTLV-I Infections / Q000097:blood / Q000235:genetics*; D015368:Human T-lymphotropic virus 1 / Q000235:genetics*; D006801:Humans; D019169:Jurkat Cells; D007963:Leukocytes, Mononuclear / Q000737:chemistry / Q000821:virology; D011533:Proviruses / Q000235:genetics*; D017735:Virus Latency
chemical_list: D004279:DNA, Viral; D016356:Gene Products, tax; C514970:tax protein, Human T-lymphotrophic virus 1
references.citation: J Infect Dis. 2011 Feb 15;203(4):529-36
references.pmid: 21208912
references.citation: J Virol. 2011 Jun;85(11):5384-93
references.pmid: 21430059
references.citation: J Biol Chem. 2003 Aug 29;278(35):33528-39
references.pmid: 12796494
references.citation: PLoS Pathog. 2010 Sep 23;6(9):e1001117
references.pmid: 20886101
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:2889-903
references.pmid: 19273242
references.citation: Nucleic Acids Res. 2008 Sep;36(16):5221-31
references.pmid: 18684996
references.citation: Genome Biol. 2010;11(8):R86
references.pmid: 20738864
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5187-91
references.pmid: 19279218
references.citation: J Biol Chem. 2012 Sep 7;287(37):30897-905
references.pmid: 22952240
references.citation: Proc Natl Acad Sci U S A. 2007 May 8;104(19):8035-40
references.pmid: 17483473
references.citation: Science. 2003 Mar 14;299(5613):1713-6
references.pmid: 12589003
references.citation: PLoS Biol. 2011 Nov;9(11):e1001206
references.pmid: 22140357
references.citation: PLoS Genet. 2011 Mar;7(3):e1002008
references.pmid: 21408204
references.citation: Nat Med. 2005 Dec;11(12):1287-9
references.pmid: 16311605
references.citation: Blood. 2012 Oct 25;120(17):3488-90
references.pmid: 22955925
references.citation: J Virol. 1995 Apr;69(4):2649-53
references.pmid: 7533860
references.citation: Cell Host Microbe. 2008 Aug 14;4(2):123-33
references.pmid: 18692772
references.citation: J Virol. 2010 May;84(9):4755-68
references.pmid: 20164218
references.citation: J Infect Dis. 2004 Jun 15;189(12):2294-8
references.pmid: 15181578
references.citation: Mol Cell. 2001 Jun;7(6):1245-54
references.pmid: 11430827
references.citation: J Biol Chem. 2003 Jan 3;278(1):372-81
references.pmid: 12407101
references.citation: PLoS Pathog. 2012 Jan;8(1):e1002480
references.pmid: 22291590
references.citation: Nucleic Acids Res. 2004 Jan 1;32(Database issue):D493-6
references.pmid: 14681465
references.citation: Science. 1994 Dec 23;266(5193):2002-6
references.pmid: 7801128
references.citation: Retrovirology. 2005 Oct 22;2:64
references.pmid: 16242045
references.citation: Genome Res. 2005 Oct;15(10):1451-5
references.pmid: 16169926
references.citation: J Virol. 1995 May;69(5):2863-8
references.pmid: 7707509
references.citation: PLoS Pathog. 2008 Mar 21;4(3):e1000027
references.pmid: 18369476
references.citation: Eur J Immunol. 2009 Jul;39(7):1700-12
references.pmid: 19582737
references.citation: Int Immunol. 1991 Aug;3(8):761-7
references.pmid: 1911545
references.citation: Nature. 2012 Sep 6;489(7414):57-74
references.pmid: 22955616
references.citation: Oncogene. 2011 Mar 24;30(12):1379-89
references.pmid: 21119600
references.citation: J Virol. 2002 Dec;76(24):12813-22
references.pmid: 12438606
references.citation: J Virol. 2007 Jun;81(12):6731-41
references.pmid: 17409138
references.citation: Gan. 1980 Feb;71(1):155-6
references.pmid: 6966589
references.citation: Blood. 2000 Feb 15;95(4):1386-92
references.pmid: 10666215
references.citation: PLoS Comput Biol. 2010 Nov 24;6(11):e1001008
references.pmid: 21124862
references.citation: Blood. 2011 Mar 17;117(11):3113-22
references.pmid: 21228324
references.citation: Mol Cell Biol. 2011 Apr;31(7):1512-27
references.pmid: 21262765
references.citation: Blood. 2009 Jul 30;114(5):1016-25
references.pmid: 19494354
references.citation: J Biol Chem. 2005 Aug 19;280(33):29653-60
references.pmid: 15975923
references.citation: J Neurovirol. 2001 Jun;7(3):228-34
references.pmid: 11517397
references.citation: Immunity. 2000 Nov;13(5):657-64
references.pmid: 11114378
references.citation: Methods. 2009 Apr;47(4):291-7
references.pmid: 19232540
references.citation: Retrovirology. 2005 Dec 09;2:75
references.pmid: 16336683
references.citation: J Immunol. 2009 May 1;182(9):5723-9
references.pmid: 19380819
references.citation: Trends Immunol. 2012 Nov;33(11):554-62
references.pmid: 22867874
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
references.pmid: 16407133
references.citation: J Virol. 1990 Nov;64(11):5682-7
references.pmid: 1976827
references.citation: Virology. 1992 Jun;188(2):628-36
references.pmid: 1374983
references.citation: Oncogene. 2005 Sep 5;24(39):5986-95
references.pmid: 16155605
references.citation: J Neurovirol. 1998 Dec;4(6):586-93
references.pmid: 10065900
references.citation: Blood. 2010 Aug 26;116(8):1211-9
references.pmid: 20448111
references.citation: Nature. 1990 Nov 15;348(6298):245-8
references.pmid: 2146511
references.citation: J Virol. 2009 Feb;83(4):2048-54
references.pmid: 19073733
references.citation: Cell Host Microbe. 2008 Aug 14;4(2):134-46
references.pmid: 18692773
references.citation: Curr Protoc Mol Biol. 2010 Jan;Chapter 19:Unit 19.10.1-21
references.pmid: 20069535